##gff-version 3
##sequence-region Q9Y4C4 1 1052
Q9Y4C4	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22814378;Dbxref=PMID:22814378	
Q9Y4C4	UniProtKB	Chain	2	1052	.	.	.	ID=PRO_0000308609;Note=Malignant fibrous histiocytoma-amplified sequence 1	
Q9Y4C4	UniProtKB	Repeat	64	85	.	.	.	Note=LRR 1	
Q9Y4C4	UniProtKB	Repeat	88	109	.	.	.	Note=LRR 2	
Q9Y4C4	UniProtKB	Repeat	112	133	.	.	.	Note=LRR 3	
Q9Y4C4	UniProtKB	Repeat	136	157	.	.	.	Note=LRR 4	
Q9Y4C4	UniProtKB	Repeat	159	180	.	.	.	Note=LRR 5	
Q9Y4C4	UniProtKB	Repeat	182	203	.	.	.	Note=LRR 6	
Q9Y4C4	UniProtKB	Repeat	205	226	.	.	.	Note=LRR 7	
Q9Y4C4	UniProtKB	Repeat	228	249	.	.	.	Note=LRR 8	
Q9Y4C4	UniProtKB	Repeat	251	272	.	.	.	Note=LRR 9	
Q9Y4C4	UniProtKB	Repeat	274	296	.	.	.	Note=LRR 10	
Q9Y4C4	UniProtKB	Repeat	297	318	.	.	.	Note=LRR 11	
Q9Y4C4	UniProtKB	Repeat	320	341	.	.	.	Note=LRR 12	
Q9Y4C4	UniProtKB	Repeat	343	364	.	.	.	Note=LRR 13	
Q9Y4C4	UniProtKB	Domain	403	649	.	.	.	Note=Roc;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00758	
Q9Y4C4	UniProtKB	Region	64	649	.	.	.	Note=Required for interaction with PPP2R2A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28609714;Dbxref=PMID:28609714	
Q9Y4C4	UniProtKB	Region	64	364	.	.	.	Note=Required for interaction with PJA2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28471450;Dbxref=PMID:28471450	
Q9Y4C4	UniProtKB	Site	1000	1001	.	.	.	Note=Breakpoint for translocation to form chimeric MASL1	
Q9Y4C4	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22814378;Dbxref=PMID:22814378	
Q9Y4C4	UniProtKB	Modified residue	601	601	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q9Y4C4	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_036846;Note=L->V;Dbxref=dbSNP:rs34984230	
Q9Y4C4	UniProtKB	Natural variant	892	892	.	.	.	ID=VAR_036847;Note=L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:9973190;Dbxref=dbSNP:rs429433,PMID:15489334,PMID:9973190	
Q9Y4C4	UniProtKB	Mutagenesis	414	556	.	.	.	Note=Dominant negative effect on the ERK1/ERK2 signaling pathway and EPO-induced erythroid differentiation. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23327923;Dbxref=PMID:23327923	
Q9Y4C4	UniProtKB	Mutagenesis	443	443	.	.	.	Note=Loss of GTP-binding. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24286120;Dbxref=PMID:24286120	
Q9Y4C4	UniProtKB	Mutagenesis	450	450	.	.	.	Note=Dominant negative effect on the ERK1/ERK2 signaling pathway and EPO-induced erythroid differentiation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23327923;Dbxref=PMID:23327923	
Q9Y4C4	UniProtKB	Sequence conflict	529	529	.	.	.	Note=H->N;Ontology_term=ECO:0000305;evidence=ECO:0000305	
